Accès ouvert
2026
article
OpenAlex
Rodrigo Almeida Toledo, Carlota Arenillas, Patricia L. M. Dahia, Judith Favier et autres
The HIF-2α inhibitor belzutifan was recently U.S. Food and Drug Administration (FDA)-approved for advanced pheochromocytoma/paraganglioma. This multistakeholder article calls for clinical-trial genomic correlates and outcome data to clarify efficacy across these molecularly heterogeneous neuroendocrine tumors.
es, us, nl, gb, fr, au, de, br, jp, ca, cn, ch, cz
(code pays fourni par la source)
2025
conference-abstract
OpenAlex
Lorenzo Tucci, Biase Dario De, Juliane Lippert, Lisa M. James et autres
2025
conference-abstract
OpenAlex
Emanuela Esposito, Lucy Beevors, Vasileios Chortis, Laura‐Sophie Landwehr et autres
2025
conference-abstract
OpenAlex
Lorenzo Tucci, Ana Crastin, Ezra Leander Santosh David Onesimu, Alessandro Prete et autres
Accès ouvert
2025
article
OpenAlex
Rosa Catalano, Emma Nozza, Barbara Altieri, Emanuela Esposito et autres
Supplementary Material 4
it, de, us, gr, ch, gb
(code pays fourni par la source)
Accès ouvert
2024
preprint
OpenAlex
Katia Mariniello, James F. H. Pittaway, Barbara Altieri, Kleiton Silva Borges et autres
Abstract Disruption of processes involved in tissue development and homeostatic self-renewal is increasingly implicated in cancer initiation, progression, and recurrence. The adrenal cortex is a dynamic tissue that undergoes life-long turnover. Here, using genetic fate mapping and murine adrenocortical carcinoma (ACC) models, …
gb, de, us, fi, ch, it
(code pays fourni par la source)
2021
conference-abstract
OpenAlex
Quratulain Yousuf, Yasir Elhassan, Wiebke Arlt, Qazi Jehanzeb et autres
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
2019
conference-abstract
OpenAlex
Vasileios Chortis, Irina Bancos, Thomas H. Nijman, Lorna C Gilligan et autres
Searchable abstracts of presentations at key conferences in endocrinology ISSN 1470-3947 (print) | ISSN 1479-6848 (online)